No association between the DRD3 Ser9Gly polymorphism and schizophrenia

Area of Science:

• Neurogenetics
• Psychiatric Genetics
• Molecular Psychiatry

Background:

• Schizophrenia is a complex psychiatric disorder with a significant genetic component.
• The dopamine D3 receptor (DRD3) gene has been implicated in the pathophysiology of schizophrenia.
• Specific polymorphisms within the DRD3 gene are investigated as potential risk factors.

Purpose of the Study:

• To examine the association between the Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and schizophrenia.
• To determine if this specific DRD3 genetic variation contributes to schizophrenia susceptibility.

Main Methods:

• Case-control study comparing genotype and allele frequencies of DRD3 Ser9Gly in 408 schizophrenic patients and 172 controls.
• Family-based association study using the Transmission Disequilibrium Test (TDT) on 183 pedigrees (472 subjects).

Main Results:

• No significant differences in genotype or homozygosity distributions were found between patients with schizophrenia and control subjects.
• Stratified analyses by gender, treatment response, and age at onset revealed no significant associations.
• The Transmission Disequilibrium Test indicated no preferential transmission of the Ser9 (Allele A) or Gly9 (Allele G) alleles from parents to affected offspring.

Conclusions:

• The findings do not support the hypothesis that the DRD3 Ser9Gly polymorphism plays a predisposing role in the development of schizophrenia.
• This specific DRD3 genetic variant is unlikely to be a significant risk factor for schizophrenia in the studied population.